Automated Patch Clamping Trends 2014

Publisher Name :
Date: 17-Apr-2014
No. of pages: 54

Executive Summary

  • This market report summarizes the results of HTStec’s industry-wide global web-based benchmarking survey on ion channel drug screening using automated patch clamping (APC) technology carried out in March 2014.
  • The study was initiated by HTStec as part of its ongoing tracking of life science marketplaces. The questionnaire was compiled to meet the needs and interests of ephys/APC vendor community.
  • The objective of this global benchmarking study was to comprehensively document current practices, preferences and metrics in ion channel drug screening using APC technology. It also seeks to chart the emergence of new 384-well APC systems, what determines APC consumable budgets, and most prevents end-users making greater use of APC consumables. In addition, a secondary focus was to understand respondents’ interests and requirements in using a new APC technology for the analysis of adherent cellular 2D networks.
  • Equal emphasis was given to soliciting opinion from Pharma, Other Screening Labs and Academic Research segments in North America, Europe and Japan.
  • The survey looked at the following aspects of ion channel screening using APC technology, as practiced to date (2014) and in some cases as predicted for the future (2016): ion channels classes of greatest interest; ion channels that have proved most difficult to run as primary screens; number of ion channel programs investigated; primary drivers for initiating a new ion channel programs; areas of drug discovery applying APC technologies; typical size of the compound library in drug discovery areas using an APC platform; number of APC patch wells expected to processed per year; proportion of APC assays using different cell types; current access to APC ion channel platforms; preferred vendor’s APC systems for different criteria; likelihood of purchasing a new APC platform over the next few years; factors that most influence a decision to purchase a particular APC platform; APC consumables budget for ion channel screening and how they are determined; what factors most prevent making greater use of APC consumables today; whether the recent introduction of new 384-well APC screening platforms will affect screening activities; prohibitive and stimulative 384-well APC consumable pricepoints; and awareness of the FDA CIPA working group and its potential impact on safety assays undertaken. With respect to a new APC system for adherent 2D cellular networks the following were investigated: technologies already used to obtain information on cell-cell communication within cellular 2D networks; what respondents most want to analyze with the system; applications most suited to the system; cell types most likely to be used with the system; main advantages of the system; impact of the potential disadvantages of the system; features essential for the adoption and exploitation of the system; optimal patch combinations; usefulness of the potential throughput likely to be achieved with the system; preferred routes to access and fit to existing workflow of the system; reasonable price to pay for the APC system; likelihood of future purchasing of the system; reasonable APC consumable pricing for the system; and interest to receive more information/testing of the system.
  • The survey questionnaire consisted of 32 mainly multi-choice questions. In addition, there were 6 questions related solely to survey demographics.
  • The survey collected 88 validated responses, of these 63% provided comprehensive input.
  • Survey responses were geographically split: 34% North America; 31% Europe; 30% Japan; 2% China; 2% Rest of World; and 1% India.
  • Survey respondents were drawn from persons or groups actively involved in ion channel screening, selectivity profiling and safety assessment against ion channel liabilities using APC systems.
  • Respondents represented: 20 Medium-Small Pharma; 17 University/ Research Institute/Government Labs/ Not-for-Profit; 16 Large Pharma; 15 Biotech Company; 9 Contract Research Organisation; 6 Biopharma; 2 Academic Screening Center; 1 Agrochemical/Agri-Biotech Company; 1 Tobacco Company and 1 Other.
  • Most survey respondents had a senior job role or position which was in descending order: 20 research scientists/associates; 20 senior scientists/researchers; 12 principal investigators; 9 section/group leaders; 5 post-docs; 5 department heads; 5 directors; 4 lab managers; 4 professors/assistant professors; 2 vice presidents; and 2 others.
  • Survey results were expressed as an average of all survey respondents. In addition, where appropriate the data was reanalyzed after sub-division into the following 6 survey groups: 1) Pharma; 2) Other Screening Labs; 3) Academic Research; 4) Europe; 5) North America; and 6) Japan.
  • The ion channel research activity most undertaken by respondents was secondary screening.
  • The class of ion channels of most interest was voltage-gated potassium channels. The class of ion channels most experienced difficulty running as primary screens was voltage-gated calcium channels.
  • A median of 3 ion channel programs were under investigation in respondent’s organisation.
  • The primary driver for initiating a new ion channel program was the disease focus of the company.
  • APC technologies were most used today for assay development and hits-to-leads (lead optimization).
  • The median compound library size tested using APC was: 1K-5K for primary screening/HTS; <1K for all hit-to-lead follow-up; and <1K for early non-compliant hERG liability testing.
  • The median number of APC wells processed/year was: 5K-10K for primary screening/HTS; 1K-5K for all hit-to-lead follow-up; and 1K-5K for early non-compliant hERG liability testing.
  • The cell type they most used for APC assays today was recombinant cell lines.
  • The most common APC system available for use in respondents’ labs was the Sophion QPatch 8, 16 or HT.
  • From current prevalence of APC instruments Molecular Devices & Sophion have the greatest vendor share.
  • Of a list of relevant criteria Molecular Devices was the preferred vendor’s APC system with respect cost per consumable, cost per data point and throughput. Sophion was the preferred vendor’s APC system with respect to the 11 other important criteria rated.
  • The median likelihood respondents will purchase a new APC platform over the next few years (by end of 2016) was low (<10% purchasing probability).
  • APC platforms currently most appealing for purchasing were Sophion Qube & Nanion Syncropatch 384PE.
  • The quality of the results was the factor which would most influence a decision to purchase a particular brand/model of APC platform.
  • The median annual APC consumable budget was $50K-$100K/year today.
  • Several bottom-up models were developed around the respondent’s feedback to calculate the global APC markets. In 2014 these were estimated to be around $140M for APC consumables and $38M for new APC platforms. Segmentation & some CAGR estimates are in the full report.
  • The APC consumable budget for ion channel testing of most respondents was not fixed i.e. it can be adjusted to reflect cost changes per data point.
  • The factors that most prevent greater use of APC consumables today were the high cost of APC consumables and lack of ion channel projects.
  • The most predicted effect of the introduction of new 384-well APC screening platforms was to increase the number of data points screened, but with a similar consumable budget.
  • For new 384-well APC screening platforms the median prohibitive pricepoint (i.e. limits use to certain applications & inhibits adoption) was $1.00 per APC data point and $350-$450 per 384-well patch plate.
  • The majority were aware of the FDA CIPA working group where the cardiac risk panel was questioned.
  • The most investigated technology to obtain information on cell-cell communication within a 2D cellular network was manual patch clamp.
  • A new APC system in development for the analysis whole-cell and cell-attached-measurements of individual cells (e.g. neural or cardiac) in an adherent cellular 2D network was presented. The following feedback was obtained with respect to the technology in general or to the proposed academic APC system: 1) analyzing more than one adherent cell from a network in parallel was rated where greatest interest resides; 2) analyzing neuronal networks in general was rated the most suitable application; 3) primary neurons and recombinant cell lines were the cell types most would like to investigate; 4) allows for analysis of cell-cell communication was ranked as the greatest advantage; 5) the need to invest in a new APC system to measure cellular 2D networks was rated the biggest limitation; 6) extracellular perfusion of the whole well was selected as the most essential feature for adopting and exploiting the system; 7) the most wanted patch combination was 100-150 μm patch-to-patch distance, 2 patch sites per chip; 8) the throughput detailed (10 networks per day) was moderately useful in all drug discovery areas, apart from primary screening/HTS; 9) the preferred route to access was via a fee-for-service provider as an addition to current patch-clamp techniques; 10) the median reasonable price was $100K per system; 11) the median probability of purchasing when it becomes available was overall low (<10%), but medium (10-50%) in academic labs; 12) the median reasonable price for an APC consumable was $100-$200 per single chip; and 13) 24 labs want to receive more information and 17 labs want to test the academic APC system. Feedback on the proposed pharmaceutical APC system is given the full report.
  • The full report provides the data, details of the breakdown of the responses for each question, its segmentation and the estimates for the future (2016). It also highlights some interesting differences between the survey groups.

Automated Patch Clamping Trends 2014 published by HTStec Ltd in 17 April 2014. This report consists of 54 Pages and the price starts from US $ 2500.

Automated Patch Clamping Trends 2014

Table of Contents

Executive Summary 2
Survey Methodology 5
Respondent’s Organisation And Response To The Survey 6
Respondent’s Company Or Organisational Origin 7 Respondent’s Geographic Origin 8
Respondent’s Job Role 9
Ion Channel Research Activities Undertaken By Respondents 10
Classes of Ion Channels of Most Interest to Respondents 11
Classes of Ion Channels Most Difficult To Screen 12
Number Of Ion Channel Drug Discovery Programs Under Investigation (1) 13
Number Of Ion Channel Drug Discovery Programs Under Investigation (2) 14
Primary Drivers For Initiating A New Ion Channel Program 15
Use Of APC Technologies In Different Drug Discovery Areas 16
Compound Library Size Tested Using An APC Platform 17
Number Of APC Well Processed Per Year Using An APC Platform 18
Summary of Survey Findings (1) 19
Proportion Of Different Cell Types Used In APC Assays 21
APC Platforms Respondents Currently Have Access To 22
Preferred Vendor’s APC System For Various Criteria 23
Likelihood Will Purchase A New APC Platform Over The Next Few Years 24
Number Of Units Of A New APC Platform Respondents Might Purchase 25
APC Platforms Most Appealing For Future Purchasing 26
Factors Which Would Most Influence Purchasing Of APC Platform 27
APC Consumables Budget 28
APC Market Estimates (1) 29
APC Market Estimates (2) 30
How APC Consumable Budget For Ion Channel Testing Is Determined 31
Factors Preventing Greater Use Of APC Consumables 32
How New 384 APC Platforms May Affect Screening Activities 33
APC Consumable Pricepoints For New 384-Well APC Screening Platforms 34
Awareness of FDA CIPA Working Group And Impact On Safety Assays 35
Summary of Survey Findings (2) 36
New APC System for 2D Cellular Networks (Technology Description) 38
Technologies Investigated To Obtain Information On Cell-Cell Communication With 2D Cellular Networks (1) 39 Technologies Investigated To Obtain Information On Cell-Cell Communication With 2D Cellular Networks (2) 40 What Respondents Most Want To Analyze With A New APC System For 2D Cellular Networks 41
Applications Most Suited To An APC System For 2D Cellular Networks 42
Preferred Cell Types For An APC Analysis System For 2D Cellular Networks 43
Main Advantages Of An APC System For 2D Cellular Networks 44
Potential Disadvantages Of An APC System For Adherent Cellular 2D Networks 45
Features Needed In A New APC System For Analysis Of Cellular 2D Networks 46
Patch Combinations Most Optimal For Respondent’s Research 47
Throughput Needed For Analysis 2D Cellular Networks 48
Preferred Route To Access A New APC System For Cellular 2D Networks 49
Reasonable Price To Pay For A New APC System For 2D Cellular Networks Networks 50
Likelihood Of Purchasing A New APC System For Cellular 2D Networks 51
Reasonable Price To Pay For APC Consumables For 2D Cellular Networks 52
Respondents Interested In More Info Or Testing The New APC System For 2D Cellular Networks 53
Summary of Survey Findings (3) 54

  • Challenges in the Tourism Industry in Thailand
    Thailand has always been a popular tourist destination and tourism provides a major boost to the country’s economy. Bangkok, Hua Hin, Krabi, Samui, Phuket and Cha Am are some of the most attractive tourist destinations in the country. In 2012, Thailand had a very high number of arrivals. Even the number of Thai citizens who [...]
  • Future of the US Consumer Electronics Market
    The market for consumer electronics has been growing steadily. Some of the factors that are contributing to the growth in the market are technological advancement, rise in disposable income and increasing demand for new products. During 2012, consumer electronics market in the US demonstrated positive expansion, although the growth rate slowed down considerably following the [...]
  • Overview of the Global Retail Market
    The global retail industry continued to grow despite the difficult economic conditions in the world. In the fiscal year of 2011, sales-weighted, currency-adjusted revenue rose by 5.1% to $4.271 trillion for the world’s top 250 retailers. According to GRDI (Global Retail Development Index), in 2013 Brazil occupied the top spot in retail development. Chile and [...]
  • Bright Future Predicted for the Tourism Industry in Singapore
    Travel and tourism industry in Singapore has been growing at a steady rate and is considered to be a major contributor to the economic growth of the country. In 2012, Singapore’s IVA (International Visitors Arrivals) reached a record high of 14.5 million, with a growth rate of 10.1% year-on-year. In recent years, inbound travel to [...]
  • Potential of Staffing Market in United States
    The staffing industry places individuals into contract, temporary and permanent positions in firms around the world. Major staffing markets include France, Spain, Italy and Japan as well as many emerging markets. Temporary staffing around the world has been growing, but in US temporary market has been flat since 2006. The majority of staffing revenue majorly [...]
  • Graft-Versus-Host Disease (GVHD) Treatment Market worth $407 million by 2018
  • The graft-versus-host disease (GVHD) treatment market value will increase from $297 million in 2013 to $407 million by 2018, at a Compound Annual Growth Rate (CAGR) of 6.59%, according to research and consulting firm GlobalData. The company’s latest report* states …

  • Poland Pharmaceutical Industry Growing at 8.3% CAGR to 2020
  • Factors such as the growing elderly population, increasing availability of affordable medicines, and transparent regulatory guidelines will provide the necessary impetus for the growth of the Polish pharmaceutical market, but a decrease in mark-up prices and the country’s stringent drug …

  • Asia-Pacific, Led by China, Drive the Global Methanol Industry
  • China is driving the global methanol industry, with tremendous demand from both its energy and petrochemicals sectors. It accounts for 87.9% of Asia-Pacific’s (APAC) methanol capacity, and 51.9% of the global methanol capacity. Despite a large planned capacity increase in …

  • Diagnostic X-ray Imaging Market worth $4.0 billion by 2020
  • GlobalData estimates that the global diagnostic X-ray imaging market, worth $2.4 billion in 2012, will reach almost $4.0 billion by 2020, increasing at a Compound Annual Growth Rate (CAGR) of 6.7% during the forecast period. Many players are active in …

  • Graft-Versus-Host Disease Market Forecast to 2023
  • Graft-versus-host disease (GVHD) is a common complication of allogeneic hematopoietic stem cell transplantation (HSCT) that occurs when the donated (graft) cells are rejected and attack the host’s cells as foreign. GVHD can progress from mild to severe forms as either …

  • Global Non–Invasive Prenatal Testing Market, Test Volume & Forecast
    Published: 27-Oct-2014        Price: US $1400 Onwards        Pages: 67
    The development of the non–invasive prenatal test (NIPT) has transformed the prenatal testing market. NIPT has the potential to drastically change how pregnancies are managed. Non–invasive prenatal genetic testing (NIPT) has been commercially available since 2011 and has been rapidly adopted in the US and in parts of Europe. Recently, companies have also started marketing NIPT in low– and middle–income countries (LMICs). Sequenom, Inc. was the first company that offered its proprietar......
  • Surgical Imaging Market by Product (Mobile C-arm/ Mini C-arm) & by Application (Orthopedic and Trauma/Neurosurgery/Cardiovascular/Hand and Wrist/ Foot and Ankle/ Pediatric) – Competitive Landscape, Global Forecasts & Trends to 2019
    Published: 22-Oct-2014        Price: US $4650 Onwards        Pages: 132
    The global surgical imaging market was valued at an estimated $933.6 million in 2014 and is expected to grow at a CAGR of 6.0% from 2014 to 2019. North America accounted for the largest share of the global surgical imaging market followed by Europe and Asiavalued at $378.6 million in 2014.The dominance of the North American market can be attributed to reasons such as the increasing prevalence of sports injuries in this region as well as the availability of private and government funding for t......
  • Global Coagulation Testing Market 2014-2018
    Published: 22-Oct-2014        Price: US $2500 Onwards        Pages: 72
    Coagulation tests help in measuring the clotting ability of blood. Clotting is the process of blood converting from liquid into gel form. Coagulation tests are performed to analyze clotting disorders such as hemorrhage and thrombosis. Coagulation tests include complete blood count, factor V assay, fibrinogen level, prothrombin time, platelet count, thrombin time, and bleeding time. Coagulation testing analyzers play a major role in improving patients' quality of life. TechNavio's analysts for......
  • Global Drug Abuse Testing Market 2014-2018
    Published: 22-Oct-2014        Price: US $2500 Onwards        Pages: 75
    Drugs are chemical substances, which are generally used in the diagnosis, treatment, and prevention of diseases. Drugs when used as medicines have positive effects on patients; however, some people use drugs for non-medical purposes, which leads to serious health problems. Drug abuse testing is a technical analysis of biological specimen to determine the drugs or combination of drugs consumed by a person. The biological specimens used for the test are saliva, urine, blood, hair, breath, and swea......
  • Global Preimplantation Genetic Diagnosis (PGD) Market 2014-2018
    Published: 22-Oct-2014        Price: US $2500 Onwards        Pages: 52
    Preimplantation genetic diagnosis (PGD) testing involves the identification of genetic defects in embryos. It is performed to identify single gene disorders such as Sickle Cell Anemia, Cystic Fibrosis, Huntington's Disease, Hemophilia, Marfan's Disease, Thalassemia, Muscular Dystrophy, Tay Sachs, and Spinal Muscular Atrophy. PGD tests are generally carried out in cases of a known genetic defect, or in late age pregnancy, or in patients with a history of repeated miscarriages. PCR, FISH, CGH, and......
  • China Independent Clinical Laboratory Industry Report, 2014-2017
    Published: 21-Oct-2014        Price: US $1850 Onwards        Pages: 78
    The independent clinical laboratory industry starts relatively late in China, featuring a limited overall size but high-speed development. In 2013 the independent clinical laboratory market size there was around RMB3.5 billion, up as much as 70% yr-on-yr, yet only accounting for 2%-3% of the total revenue of medical diagnosis. There are about 110 independent clinical laboratories in today’s China, but most of them are small sized. KingMed Diagnostics, ADICON, DIAN Diagnostics and DAAN Gene ......
  • Optical Imaging Market by Technique (Optical Coherence Tomography, Hyperspectral Imaging, Photoacoustic Tomography), Product (Imaging System, Imaging software) & by Application (Ophthalmology, Neurology, Oncology, Cardiology) – Global Forecasts to 2019
    Published: 17-Oct-2014        Price: US $4650 Onwards        Pages: 225
    Over the last decade, the optical imaging market has grown, primarily due to the widening applications of optical imaging techniques, the increased demand for safer and noninvasive imaging modalities, and a rising need to minimize the use of radiation in diagnostic imaging. The fast-growing pharmaceutical and biotechnology industries are also catalyzing the growth of the optical imaging market. In this report, the global optical imaging market is segmented by techniques, products, application......
  • Global Digital Pathology Market 2014-2018
    Published: 15-Oct-2014        Price: US $2500 Onwards        Pages: 80
    Digital pathology includes managing, interpreting, and analysing the digital information. It also termed as virtual microscopy or virtual pathology. It includes the process of developing glass images and then converting to digital slides with the digital solutions. Digital pathology is used by many users such as forensic pathology, oral pathology, human pathology, and veterinary pathology. The increased benefits of the digital pathology is driving the market. Digital pathology has changed the wa......
  • Picture Archiving and Communication Systems Market to 2020 – Digitization of Healthcare Systems and Evolution of PACS as a Decision Support Tool Drive Growth
    Published: 1-Oct-2014        Price: US $3500 Onwards        Pages: 68
    GBI Research’s report, “Picture Archiving and Communication Systems Market to 2020 - Digitization of Healthcare Systems and Evolution of PACS as a Decision Support Tool Drive Growth” discusses the market, competitive landscape, and trends for two Picture Archiving and Communications Systems (PACS) market segments: radiology PACS and cardiology PACS. It provides comprehensive information on the key trends affecting these segments, and key analytical content on the dynamics of the overall ma......
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs